The efficacy of low-dose systemic opioids for chronic breathlessness was questioned by the recent Cochrane review by Barnes et al. We examined the reasons for this conflicting finding and re-evaluated the efficacy of systemic opioids. Compared with previous meta-analyses, Barnes et al reported a smaller effect and lower precision, but did not account for matched data of crossover trials (11/12 included trials) and added a risk-of-bias criterion (sample size). When re-analysed to account for crossover data, opioids decreased breathlessness (standardised mean differences -0.32; -0.18 to -0.47; I 2 =44.8%) representing a clinically meaningful reduction of 0.8 points (0-10 numerical rating scale), consistent across meta-analyses.
CITATION STYLE
Ekström, M., Bajwah, S., Bland, J. M., Currow, D. C., Hussain, J., & Johnson, M. J. (2018). One evidence base; Three stories: Do opioids relieve chronic breathlessness. Thorax, 73(1), 88–90. https://doi.org/10.1136/thoraxjnl-2016-209868
Mendeley helps you to discover research relevant for your work.